New York, NY (PRWEB) April 30, 2014
The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. A new report shows the number of Yaz settlements for claims alleging side effects has risen for April*.
DrugNews is a free resource that provides the latest product recalls, safety alerts, research and litigation news for patients taking popular prescription drugs. Visitors can recognize potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts such as the FDA** and British Medical Journal*** that birth controls like Yaz and Yasmin, which contain drospirenone, can increase risks of blood clots. The U.K.’s Medicines and Healthcare Products Regulatory Agency also recently advised certain meds like Yasmin can double the risk of blood clots****.
Due to the number of patients that have filed a Yaz lawsuit alleging side effects, cases have been consolidated in a special federal court (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
The latest court records show the number of Yaz cases still pending declined over 1% for the month of April, from 9,550 on March 13 to 9,426 on April 15th*****.
Now, DrugNews has learned the maker of the drugs, Bayer, has spent $1.74 billion through April 8th to settle around 8,560 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT), and they will continue to evaluate new cases for settlement*.
Lawyers are still helping those injured. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is encouraged to visit DrugNews or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have settled hundreds of Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*Bayer 2014 Q1 Report, Explanatory Notes, Legal Risks, 4/28/14; stockholders-newsletter-q1-2014.bayer.com/en/explanatory-notes.aspx#legalrisks
**FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
****British Journal of Family Medicine, Feb 2014; bjfm.co.uk/content/article.aspx?id=25769806997
*****JPML, 4/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-April-15-2014.pdf